The legal action, initiated by Pomerantz LLP, centers on allegations of securities fraud and potential corporate misconduct by XTI leadership. The scrutiny follows an August 17, 2026, regulatory disclosure in which the company admitted it could not file its quarterly report on time. The firm cited an ongoing internal review concerning its former CEO, who stepped down on the same day the delay was announced.

Market reaction to the disclosure was immediate. XTI shares dropped $0.25, or nearly 16 percent, to close at $1.32 on August 18. Investors seeking to participate in the litigation or obtain further details on the complaint may contact Danielle Peyton at Pomerantz LLP.